Recombinant multi-species OGG1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine OGG1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes the enzyme responsible for the excision of 8-oxoguanine, a mutagenic base byproduct which occurs as a result of exposure to reactive oxygen. The action of this enzyme includes lyase activity for chain cleavage. Alternative splicing of the C-terminal region of this gene classifies splice variants into two major groups, type 1 and type 2, depending on the last exon of the sequence. Type 1 alternative splice variants end with exon 7 and type 2 end with exon 8. All variants share the N-terminal region in common, which contains a mitochondrial targeting signal that is essential for mitochondrial localization. Many alternative splice variants for this gene have been described, but the full-length nature for every variant has not been determined. [provided by RefSeq, Aug 2008]
The Alternative Names of target: HMMH,HOGG1,MUTM,Mmh,N-glycosylase/DNA lyase,OGG1,OGH1,Ogg1

Target products collectionGo to OGG1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T92189-Ag-1/ GM-Tg-hg-T92189-Ag-2 Human OGG1 protein Human
GM-Tg-rg-T92189-Ag-1/ GM-Tg-rg-T92189-Ag-2 Rat OGG1 protein Rat
GM-Tg-mg-T92189-Ag-1/ GM-Tg-mg-T92189-Ag-2 Mouse OGG1 protein Mouse
GM-Tg-cynog-T92189-Ag-1/ GM-Tg-cynog-T92189-Ag-2 Cynomolgus/Rhesus macaque OGG1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T92189-Ag-1/ GM-Tg-felg-T92189-Ag-2 Feline OGG1 protein Feline
GM-Tg-cang-T92189-Ag-1/ GM-Tg-cang-T92189-Ag-2 Canine OGG1 protein Canine
GM-Tg-bovg-T92189-Ag-1/ GM-Tg-bovg-T92189-Ag-2 Bovine OGG1 protein Bovine
GM-Tg-equg-T92189-Ag-1/ GM-Tg-equg-T92189-Ag-2 Equine OGG1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T92189-Ag-1/ GM-Tg-hg-T92189-Ag-2; GM-Tg-rg-T92189-Ag-1/ GM-Tg-rg-T92189-Ag-2;
GM-Tg-mg-T92189-Ag-1/ GM-Tg-mg-T92189-Ag-2; GM-Tg-cynog-T92189-Ag-1/ GM-Tg-cynog-T92189-Ag-2;
GM-Tg-felg-T92189-Ag-1/ GM-Tg-felg-T92189-Ag-2; GM-Tg-cang-T92189-Ag-1/ GM-Tg-cang-T92189-Ag-2;
GM-Tg-bovg-T92189-Ag-1/ GM-Tg-bovg-T92189-Ag-2; GM-Tg-equg-T92189-Ag-1/ GM-Tg-equg-T92189-Ag-2
Products Name OGG1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name OGG1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine OGG1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.